###begin article-title 0
###xml 168 189 168 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kr&#252;ppel-like factor 4</italic>
Opposing effects of Kruppel-like factor 4 (gut-enriched Kruppel-like factor) and Kruppel-like factor 5 (intestinal-enriched Kruppel-like factor) on the promoter of the Kruppel-like factor 4 gene
###end article-title 0
###begin p 1
To whom correspondence should be addressed at: Emory University School of Medicine, Department of Medicine, Division of Digestive Diseases, 201 Whitehead Biomedical Research Building, 615 Michael Street, Atlanta, GA 30322, USA. Tel: +1 404 7275638; Fax: +1 404 727 5767; Email: vyang@emory.edu
###end p 1
###begin p 2
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 840 844 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 917 921 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 1185 1189 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 1194 1198 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 1246 1250 1246 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 1341 1345 1341 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
KLF4 (Kruppel-like factor 4 or gut-enriched Kruppel-like factor, GKLF) and KLF5 (Kruppel-like factor 5 or intestinal-enriched Kruppel-like factor, IKLF) are two closely related members of the zinc finger-containing Kruppel-like factor family of transcription factors. Although both genes are expressed in the intestinal epithelium, their distributions are different: Klf4 is primarily expressed in the terminally differentiated villus cells while Klf5 is primarily in the proliferating crypt cells. Previous studies show that Klf4 is a negative regulator of cell proliferation and Klf5 is a positive regulator of cell proliferation. In this study, we demonstrate that Klf5 binds to a number of cis-DNA elements that have previously been shown to bind to Klf4. However, while Klf4 activates the promoter of its own gene, Klf5 suppresses the Klf4 promoter. Moreover, Klf5 abrogates the activating effect of Klf4 on the Klf4 promoter and Klf4 abrogates the inhibitory effect of Klf5 on the same promoter. An explanation of this competing effect is due to physical competition of the two proteins for binding to cognate DNA sequence. The complementary tissue localization of expression of Klf4 and Klf5 and the opposing effect of the two Klfs on the Klf4 promoter activity may provide a basis for the coordinated regulation of expression of the Klf4 gene in the intestinal epithelium.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 106 129 106 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c1">1</xref>
###xml 292 293 292 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c2">2</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c3">3</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c4">4</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c5">5</xref>
###xml 674 677 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 784 787 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AP2</italic>
###xml 803 804 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c6">6</xref>
###xml 884 887 880 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AP2</italic>
###xml 903 904 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c6">6</xref>
###xml 974 983 966 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">keratin 4</italic>
###xml 1058 1059 1050 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c7">7</xref>
###xml 1138 1152 1126 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-smooth muscle</italic>
###xml 1157 1161 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22</italic>
###xml 1178 1179 1162 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c8">8</xref>
###xml 106 129 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 407 412 <span type="species:ncbi:9606">Human</span>
###xml 968 973 <span type="species:ncbi:9606">human</span>
Kruppel-like factors (KLFs) are zinc finger-containing transcription factors that exhibit homology to the Drosophila melanogaster segmentation gene product Kruppel (1). A subfamily of mammalian KLFs highly related to the erythroid Kruppel-like factor (EKLF/KLF1) has recently been described (2). This rapidly expanding subfamily currently has 12 members, which have been given numerical designations by the Human Gene Nomenclature Committee (3). KLFs can be transcriptional activators or repressors (4) and they bind to a similar DNA sequence that has either a CACCC homology or is rich in GC content (5). It is therefore not surprising that KLFs may interact with the same cis-element in the same gene. For example, both KLF12/AP2-rep and KLF9/BTEB1 bind to the CACCC element in the AP2alpha promoter (6). But, while KLF12 acts as a repressor, KLF9 acts as a strong activator of the AP2alpha promoter (6). In another example, both KLF6/Zf9 and KLF4/GKLF activate the human keratin 4 promoter through the CACCC motif and the two factors physically interact (7). Finally, both KLF4/GKLF and KLF5/IKLF bind to the CACCC element in the alpha-smooth muscle and SM22alpha promoters (8). In this case, KLF4 represses while KLF5 activates the induction of these two promoters by TGFbeta (8).
###end p 4
###begin p 5
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c10">10</xref>
###xml 633 641 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In&#160;vitro</italic>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c14">14</xref>
###xml 811 815 811 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 828 829 828 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c15">15</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c16">16</xref>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c14">14</xref>
The reciprocal effect of KLF4 and KLF5 in regulating gene expression merits additional consideration. Aside from their opposing biochemical effects on several smooth muscle gene promoters as described above, the cellular distribution and regulatory functions of KLF4 and KLF5 also exhibit an opposite pattern. For example, while Klf4 is mainly expressed in the post-mitotic differentiated villus epithelial cells of the intestinal tract (9), Klf5 is found primarily in the proliferating crypt cells (10). The cellular distribution of the two genes in the epidermis of the skin also mirrors that in the intestinal epithelium (11-13). In vitro, expression of Klf4 is associated with a process of growth arrest (9), while that of Klf5 mainly accompanies cellular proliferation (14). Moreover, forced expression of Klf4 leads to a G1/S cell cycle arrest (15,16) but that of Klf5 causes a transformed phenotype (14).
###end p 5
###begin p 6
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c17">17</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c19">19</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 799 802 799 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
Because of the relatively restricted pattern of tissue expression of Klf4, we have been characterizing factors that regulate its expression. One such factor, Cdx2, previously shown to drive differentiation of intestinal epithelial cells (17), is shown to be a transactivator of the Klf4 promoter (18,19). In addition, Klf4 is capable of transactivating the promoter of its own gene through three closely spaced GC-boxes within the promoter (18). The present study demonstrates that Klf5 binds to the same DNA cis-elements as Klf4, including those within the Klf4 promoter. However, while Klf4 activates, Klf5 represses Klf4 promoter activity. Furthermore, the two factors can abrogate each other's effect on the Klf4 promoter. Lastly, the two factors compete with each other for binding to the same cis-element. The results of these studies suggest that Klf4 and Klf5 have opposing biochemical functions in regulating expression of the Klf4 gene and may potentially be involved in a coordinated effort to orchestrate the proliferative and differentiated phenotype of the intestinal epithelium.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Plasmid constructs
###end title 8
###begin p 9
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c10">10</xref>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 408 411 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 297 300 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 460 463 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 810 813 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The eukaryotic expression construct containing full-length Klf4 (PMT3-Klf4) and the luciferase reporter construct containing 1.0 kb of the 5' flanking promoter region of the Klf4 gene (Klf4-pGL2-Luciferase) were previously described (18). The expression construct containing full-length Klf5, pBK CMV-Klf5, was generously provided by J. Lingrel (University of Cincinnati, College of Medicine) (10). An EcoRI-KpnI fragment of the full-length Klf5 cDNA from pBK CMV-Klf5 was subcloned into the PMT3 vector to create PMT3-Klf5. The two PMT3 constructs were digested with appropriate restriction endonucleases to release the zinc finger portions of Klf4 and Klf5, which were then subcloned back into the PMT3 vector to create PMT3-Klf4-ZF and PMT3-Klf5-ZF, respectively. The internal control for transfection, pRL-CMV, was purchased from Promega Corporation (Madison, WI).
###end p 9
###begin p 10
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
The prokaryotic expression vector pET-16b containing the zinc finger portion of Klf4 (amino acids 350-483) has previously been described (20). The C-terminal portion of Klf5 between amino acids 242 and 446 was cloned into the prokaryotic expression vector pET101/D. Both recombinant proteins contained a 10-histidine tag at the N-terminus and were purified by nickel affinity chromatography as described before (20). The apparent molecular weight for the resultant recombinant protein was 18 and 26 kDa, respectively, for Klf4 and Klf5.
###end p 10
###begin title 11
Preparation of nuclear extracts
###end title 11
###begin p 12
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 881 882 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Nuclear extracts containing full-length Klf4 or full-length Klf5 were prepared from COS-1 cells transfected with PMT3-Klf4 or PMT3-Klf5. Nuclear extracts from cells transfected with PMT3 alone were used as controls. Extracts from transfected cells were prepared as previously described (18). Briefly, transfected cells were rinsed with ice-cold phospate-buffered saline, scraped, harvested and pelleted. The pellets were washed with 4 pack cell volume (p.c.v.) of solution containing 10 mM Tris-HCl pH 7.8, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and a Complete Protease Inhibitor Cocktail Tablet (Roche, Indianapolis, IN). Following 10 min incubation on ice, the cells were lysed by 10 strokes of a Dounce homogenizer. Nuclei were collected by centrifugation (Sorvall Microspin) and resuspended in 2 p.c.v. of a lysis solution containing 420 mM KCl, 20 mM Tris-HCl pH 7.8, 1.5 mM MgCl2, 0.5 mM DTT, 20% glycerol and a Complete Protease Inhibitor Tablet (Roche). After incubation for 1 h at 4degreesC with gentle agitation, the solution was centrifuged and the supernatant dialyzed twice against 500 ml of 20 mM Tris-HCl pH 7.8, 100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol and a Complete Protease Inhibitor Tablet (Roche). Extracts were divided into small aliquots and immediately cryopreserved.
###end p 12
###begin title 13
Electrophoretic mobility shift assays (EMSAs)
###end title 13
###begin p 14
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P4501A1</italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c21">21</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 602 604 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 889 890 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 929 930 917 918 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
EMSAs were performed according to previously published protocols (9,20). The basic transcription element (BTE) probe contained a sequence in the promoter of the cytochrome P4501A1 gene that had previously been shown to bind to Klf4 (21). The target detection assay (TDA) probe was a previously selected consensus-binding site for KLF4 (20) and closely resembled the three GC-boxes in the promoter of the Klf4 gene (18). The GC-2 probe refers to the GC-box 2 sequence in the Klf4 promoter between nucleotide -108 and -86 that has previously been shown to bind Klf4 (18). Probes were labeled with [gamma-32P]ATP using T4 polynucleotide kinase. In each reaction, 0.5 pmol of labeled probe was used. Nuclear extracts from PMT3-, PMT3-Klf4- or PMT3-Klf5-transfected cells, or purified recombinant Klf4 or Klf5 were incubated in a volume of 30 microl containing 20 mM Tris-HCl pH 7.2, 10 mM MgCl2, 150 mM NaCl, 20 mM KCl, 5 microM ZnCl2, 0.5 mM DTT, 5% glycerol and 2 microg poly(dI*dC) on ice for 30 min. The labeled probe was then added to the reaction and the incubation continued for another 15 min at room temperature. The DNA and DNA-protein complexes were resolved from one another by native 6.0% polyacrylamide gel electrophoresis and visualized by autoradiography.
###end p 14
###begin title 15
Transfection and reporter assays
###end title 15
###begin p 16
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
###xml 438 445 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 41 56 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 367 370 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Transient transfection by lipofection of Chinese hamster ovary (CHO) cells with various DNA constructs (Klf4-pGL2-Luciferase, PMT3-Klf4, PMT3-Klf5, PMT3-Klf4-ZF and PMT3-Klf5-ZF) were performed as previously described (9,18,20). Transfections were performed in 6-well tissue culture dishes at 37degreesC for 16 h. All transfections included the internal standard pRL-CMV (Promega) to normalize for transfection efficiency. Luciferase and Renilla assays were performed using the Dual-Luciferase Assay (Promega).
###end p 16
###begin title 17
RESULTS
###end title 17
###begin title 18
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
Klf4 and Klf5 bind to similar cis-DNA elements
###end title 18
###begin p 19
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c20">20</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c21">21</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f1">1</xref>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f1">1</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f1">1</xref>
###xml 1055 1056 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f2">2</xref>
###xml 1113 1117 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 1362 1363 1362 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f2">2</xref>
We first examined whether Klf4 and Klf5 bound to similar sequences by EMSAs using radiolabeled oligonucleotides containing either an established consensus sequence for Klf4 (TDA) (20) or the BTE (21). As shown in Figure 1A, two common DNA-protein complexes were formed when the TDA probe was incubated with nuclear extracts from PMT3-, PMT3-Klf4- and PMT3-Klf5-transfected cells. However, an additional complex was formed in the reaction that contained either PMT3-Klf4- or PMT3-Klf5-transfected cells. The Klf4-TDA complex is identified by * and the Klf5-TDA complex is identified by +. The specificities of all the DNA-protein complexes were demonstrated by their gradual disappearance upon addition of increasing amounts of unlabeled probe (Fig. 1A). A similar pattern was observed when BTE was used as a probe except that the intensities of the two common bands were stronger when compared with the TDA probe (Fig. 1B). The results suggest that Klf4 and Klf5 bind to similar DNA elements. Furthermore, both Klf4 and Klf5 bound to the GC-2 probe (Fig. 2C) which represents one of three GC-box sequences in the Klf4 promoter, all of which have been shown to bind Klf4 (18). The specificities of DNA-protein interaction with all three probes were further demonstrated by the failure of an unrelated AP1 probe to compete for the formation of the complexes (Fig. 2A-C).
###end p 19
###begin title 20
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
Klf4 activates and Klf5 represses the Klf4 promoter
###end title 20
###begin p 21
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c18">18</xref>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f3">3</xref>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 686 690 686 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
Recent work from our laboratory showed that Klf4 activates the promoter of its own gene by interacting with the GC-boxes in the proximal promoter (18). To determine whether Klf5 also influences the promoter activity of the Klf4 gene, we performed co-transfection studies using the Klf4-pGL2-Luciferase reporter and a eukaryotic expression construct containing either Klf4 or Klf5. As depicted in Figure 3, PMT3-Klf4 significantly activated the Klf4 promoter when compared with PMT3 alone, confirming previous findings. In contrast, PMT3-Klf5 significantly suppressed Klf4 promoter activity when compared with PMT3 alone. Thus, Klf4 and Klf5 have opposite effects on the activity of the Klf4 promoter.
###end p 21
###begin title 22
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
Klf4 and Klf5 compete to regulate the Klf4 promoter
###end title 22
###begin p 23
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f4">4</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f3">3</xref>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 727 728 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f4">4</xref>
###xml 828 832 828 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 937 941 937 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
To further determine a possible interaction between Klf4 and Klf5 on the Klf4 promoter, we performed co-transfection experiments using the Klf4-pGL2-Luciferase reporter, a constant amount of PMT3-Klf5 and increasing amounts of PMT3-Klf4 or PMT3-Klf4-ZF. As seen in Figure 4A, in the absence of any competing Klf4, Klf5 suppressed the reporter activity, as in Figure 3. The addition of Klf4 removed this inhibitory effect in a dose-dependent fashion (solid line). In contrast, a construct including only the zinc finger portion of Klf4 failed to reverse the inhibitory effect on the Klf4 promoter (dashed line). Similarly, in a converse experiment with PMT3-Klf4 as the primary effector and Klf5 as the competing effector (Fig. 4B), Klf5 (solid line) but not Klf5-ZF (dashed line) abrogated the stimulatory effect of Klf4 on the Klf4 promoter activity. These results indicate that Klf4 and Klf5 not only exhibit an opposite effect on the Klf4 promoter, they actively compete with each other. Moreover, this competitive effect requires the full-length protein. The zinc fingers alone are not sufficient.
###end p 23
###begin title 24
Klf4 and Klf5 compete with each other for DNA binding
###end title 24
###begin p 25
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f5">5</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f5">5</xref>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f5">5</xref>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f5">5</xref>
One possibility that may explain the competing effects of Klf4 and Klf5 on the Klf4 promoter is that the two proteins may compete with each other for binding to DNA. To address this possibility, we produced purified partial-length recombinant proteins that contained the zinc finger region of Klf4 and Klf5 (Fig. 5A). When incubated individually with a labeled GC-2 probe, each protein interacted avidly with the probe (Fig. 5B). We next performed EMSA of GC-2 using a constant amount of recombinant Klf4 and increasing amounts of Klf5. As seen, Klf5 reduced the binding of Klf4 to the probe in a dose-dependent fashion (Fig. 5C). Similarly, if an increasing amount of Klf4 was incubated with a constant amount of Klf5, the binding of Klf5 to the probe also gradually diminished (Fig. 5D). These results indicate that Klf4 and Klf5 compete with each other in binding to DNA.
###end p 25
###begin title 26
DISCUSSION
###end title 26
###begin p 27
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
The present study demonstrates how two closely related Klfs exert their effects on transcription of a target gene in an opposing manner. We show that Klf5 binds to several cis-elements previously established to be the binding sites for Klf4, including TDA, BTE and GC-2, the last a native cis-element in the Klf4 promoter. However, while Klf4 activates the promoter activity of its own gene, Klf5 has exactly the opposite effect. Moreover, when present together, the two Klfs interfere with each other in modulating the Klf4 promoter activity. We also show that a possible explanation for this interfering effect is due to competition of the two proteins for binding to DNA.
###end p 27
###begin p 28
###xml 163 170 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p4501A1</italic>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP1A1</italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c21">21</xref>
###xml 333 339 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP1A1</italic>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c21">21</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c10">10</xref>
###xml 564 570 564 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP1A1</italic>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c22">22</xref>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP1A1</italic>
###xml 856 875 852 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">smooth muscle actin</italic>
###xml 880 884 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22</italic>
###xml 891 892 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c8">8</xref>
###xml 952 956 941 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SM22</italic>
###xml 1052 1053 1034 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c8">8</xref>
Opposing effects of other KLFs on the promoters of several other genes have previously been described. For example, Klf4 suppresses the activity of the cytochrome p4501A1 (CYP1A1) promoter while Sp1 activates it in a BTE-dependent fashion (21). Also, similar to the present study, Klf4 abrogates the stimulatory effect of Sp1 on the CYP1A1 gene in a dose-dependent manner. In this case, it was shown that the zinc fingers of Klf4 compete for binding to BTE with Sp1 (21). It is of interest to note that KLF5, also known as BTEB2 (10), is a strong activator of the CYP1A1 promoter (22). The findings on the CYP1A1 promoter would then be the first example in which KLF4 and KLF5 antagonize each other in regulating promoter activity. In another example, KLF4 and KLF5 bind to the same CACCC element present in the promoters of two smooth muscle genes, alpha-smooth muscle actin and SM22alpha (8). Here, KLF4 inhibits TGFbeta-dependent stimulation of the SM22alpha promoter while KLF5 further activates TGFbeta-dependent stimulation of the same promoter (8). Thus, evidence from literature to date indicates that KLF4 and KLF5 exert opposite effects on the promoters of the genes studied.
###end p 28
###begin p 29
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c11">11</xref>
###xml 424 428 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c10">10</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c13">13</xref>
###xml 612 620 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c9">9</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c21">21</xref>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c14">14</xref>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
It should be noted that the biochemical behavior of KLF4 and KLF5 described above is a reflection of their biological behavior. For example, the cellular distribution of the two Klfs in several epithelial tissues is complementary, rather than redundant, to each other. Thus, Klf4 is mainly expressed in the post-mitotic villus epithelial cells of the intestine (9) and the suprabasal epidermal cells of the skin (11), while Klf5 is expressed mostly in the proliferating cells of the crypt in the intestine (10) and the basal epidermal cells of the skin (13). Moreover, the pattern of expression of the two genes in vitro contrasts each other. Klf4 is mainly expressed in the growth-arrested cells due to serum deprivation (9), contact inhibition (9) or DNA damage (21). Expression of Klf5, on the contrary, is associated with a proliferative state as seen during serum or mitogenic stimulation (14). Based on the results of current and past studies, one may speculate that the lack of crypt expression of Klf4 in the intestinal crypt epithelium may, in part, be due to the presence of Klf5 in this compartment.
###end p 29
###begin p 30
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f5">5</xref>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf400f4">4</xref>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c23">23</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c24">24</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c10">10</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c22">22</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c25">25</xref>
A potential mechanism that may explain how Klf4 and Klf5 compete with each other to regulate the activity of the Klf4 promoter appears to be exerted at the level of DNA-protein interaction. As demonstrated in Figure 5, Klf5 actively inhibits the binding of Klf4 to the GC-2 probe, and vice versa. However, the zinc finger portion of one Klf is not sufficient in reversing the effect of the other Klf on the activity of the Klf4 promoter (Fig. 4). These results indicate that amino acid sequence outside the zinc fingers of both proteins is required for the full regulation of the Klf4 promoter. Klf4 has previously been shown to be a pleiotropic transcription factor, with activating and repressing effects (23). Mutational studies have also located the activating and repressive domains to regions outside the zinc fingers in the Klf4 polypeptide (24). KLF5, although known to be a transcription activator in most studies (10,22), can act as a repressor (25). One might therefore expect that some of these domains involved in transcriptional regulation by the two proteins are responsible for the interplay noted in the current study.
###end p 30
###begin p 31
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">caudal</italic>
###xml 250 264 250 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D.melanogaster</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx1</italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c27">27</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdx2</italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c28">28</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c32">32</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c33">33</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c34">34</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c17">17</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c35">35</xref>
###xml 250 264 <span type="species:ncbi:7227">D.melanogaster</span>
The opposing effects of Klf4 and Klf5 are reminiscent of the opposing effects of Cdx1 and Cdx2 along the crypt-villus axis of the intestinal epithelium. CDX1 and CDX2 are homeodomain transcription factors with sequence homology to the caudal gene of D.melanogaster, which in mammals are specifically expressed in the epithelium of small intestine and colon (26-29). Cdx1 is expressed in the proliferating crypt cells (27,30,31) while Cdx2 is expressed predominantly in the differentiated villus cells (28,32). Several studies have shown that CDX1 regulates cell proliferation (33,34) and CDX2 regulates cell differentiation and growth arrest (17,35).
###end p 31
###begin p 32
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c19">19</xref>
###xml 368 370 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c36">36</xref>
###xml 428 432 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4</italic>
###xml 669 671 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c19">19</xref>
###xml 948 952 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDX1</italic>
###xml 961 965 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDX2</italic>
###xml 978 980 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c37">37</xref>
###xml 1040 1050 1022 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF5/BTEB2</italic>
###xml 1123 1125 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c38">38</xref>
###xml 1150 1154 1129 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf5</italic>
###xml 1253 1255 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf400c39">39</xref>
###xml 1280 1284 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF5</italic>
###xml 1364 1368 1343 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KLF4</italic>
###xml 59 69 <span type="species:ncbi:111938">gatekeeper</span>
###xml 1034 1039 <span type="species:ncbi:10090">mouse</span>
###xml 1144 1149 <span type="species:ncbi:10090">mouse</span>
Of interest, we have recently reported that the intestinal gatekeeper adenomatous polyposis coli (APC) induces Klf4 expression via Cdx2 (19). APC is a cytoplasmic protein that modulates the oncogenic Wnt signal transduction cascade by binding to beta-catenin and promoting its phosphorylation by glycogen synthase kinase 3 beta (GSK3beta), for subsequent degradation (36). Our previous data, which showed that APC activation of Klf4 via Cdx2 occurred through a beta-catenin independent pathway, have led to our proposal that these three proteins form a part of an enterocyte-specific tumor suppressor pathway in the sequence of APC --> CDX2 --> KLF4 --> growth arrest (19). This pathway may become active as epithelial cells migrate up the intestinal villus and undergo differentiation with the simultaneous loss of proliferative potential. Interestingly, Wnt, which is the product of a proto-oncogene with opposing effects to APC, can up-regulate CDX1 but not CDX2 expression (37). Moreover, Wnt has recently been reported to induce mouse KLF5/BTEB2 through a beta-catenin independent, protein kinase C dependent pathway (38). A search of the mouse Klf5 promoter (DDBJ/EMBL/GenBank accession no. AF285184) reveals several potential CDX1 binding sites (39). We may postulate that KLF5 is regulated by Wnt via CDX1 in the proliferating intestinal crypt cells while KLF4 is regulated by APC via CDX2 in the differentiating intestinal villus cells. Crosstalk and negative regulation between these opposing pathways, at the level of KLF4 and KLF5 as shown in this paper, as well as possibly higher levels involving CDX1, CDX2, Wnt and APC, tightly coordinate the intestinal epithelial cells as they proliferate, migrate and differentiate. Current studies are underway to address these interactions.
###end p 32
###begin title 33
Figures and Tables
###end title 33
###begin p 34
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 340 343 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 367 370 363 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 379 382 375 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
 EMSAs of Klf4 and Klf5 on two cis-elements, TDA and BTE. EMSAs were performed using 10 microg nuclear extracts prepared from COS-1 cells transfected with an expression construct containing vector alone (PMT3), full-length Klf4 (PMT3-Klf4), or full-length Klf5 (PMT3-Klf5) and two radiolabeled oligonucleotide probes containing established cis-elements for Klf4: TDA (A) and BTE (B). Where indicated, an unlabeled cognate oligonucleotide was used as a competitor at 5x and 10x molar excess of the labeled probe. * represents the shifted Klf4-probe complex and + represents the shifted Klf5-probe complex. N.E., nuclear extracts.
###end p 34
###begin p 35
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 389 392 385 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 398 401 394 397 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
###xml 411 414 407 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C)</bold>
 EMSAs of Klf4 and Klf5 on an additional cis-element, GC-2, that is present in the Klf4 promoter. EMSAs were performed with 10 microg nuclear extracts (N.E.) prepared from cells transfected with PMT3, PMT3-Klf4 or PMT3-Klf5 in the absence of any competitors (0), or in the presence of 25x molar excess of a cognate competitor (WT) or an unrelated competitor (AP1). Probes used include TDA (A), BTE (B) and GC-2 (C). * represents the shifted Klf4-probe complex and + represents the shifted Klf5-probe complex.
###end p 35
###begin p 36
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 258 265 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 379 380 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 483 490 479 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 553 554 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 569 570 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 592 593 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
 The opposite effects of Klf4 or Klf5 on the Klf4 promoter. Five micrograms each of the Klf4-pGL2-Luciferase reporter and PMT3, PMT3-Klf4 or PMT3-Klf5 and 2 microg pCMV-RL were co-transfected into CHO cells using Lipofectamine reagent (Promega). Firefly and Renilla luciferase assays were determined 24 h after transfection. Shown are the means of three independent experiments (n = 3) performed in triplicate. Relative luciferase activity was standardized with the internal control Renilla luciferase activity. Bars represent standard deviations. ** = P < 0.01, *** = P < 0.001 by Student's t-test compared with PMT3 vector control.
###end p 36
###begin p 37
###xml 62 65 62 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 291 294 291 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klf4&#8211;</italic>
###xml 619 626 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 739 740 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 951 952 947 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 966 967 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 988 989 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
 The competing effects of Klf4 and Klf5 on the Klf4 promoter. (A) Five micrograms each of Klf4-pGL2-Luciferase reporter and effector 1 (PMT3-Klf5) were co-transfected into CHO cells in presence of increasing amounts of effector 2: either PMT3-Klf4 (solid line) or PMT-Klf4-ZF (dashed line). (B) Five micrograms each of Klf4-pGL2-Luciferase reporter and effector 1 (PMT3-Klf4) were co-transfected into CHO cells with increasing amounts of effector 2: either PMT3-Klf5 (solid line) or PMT3-Klf5-ZF (dashed line). The total amount of DNA transfected was kept constant at 25 microg by the addition of PMT3 DNA. Firefly and Renilla luciferase assays were determined 24 h after transfection. Shown are the means of four independent experiments (n = 4) performed in triplicate. The relative activity was determined from dividing the reporter activity of effector 1-transfected cells by that of PMT3-transfected cells. Bars represent standard deviations. * = P < 0.05, ** = P < 0.01 by Student's t-test comparing full-length with zinc finger only-containing constructs.
###end p 37
###begin p 38
###xml 59 62 59 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 363 366 363 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B)</bold>
###xml 507 510 507 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C)</bold>
###xml 608 611 608 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D)</bold>
 The competing effects of Klf4 and Klf5 on binding to DNA. (A) Purified recombinant proteins containing the zinc finger portion of Klf4 (*) and Klf5 (+) are shown in this Commassie blue-stained gel. The apparent molecular weight for Klf4 is 18 kDa and that for Klf5 is 26 kDa. The arrow points to a degradation product of Klf5, which apparently binds to DNA (B). (B) EMSAs of recombinant Klf4 and Klf5 on the GC-2 probes. Increasing amounts of purified recombinant Klf4 or Klf5 were used in the experiment. (C) EMSAs were performed using a constant amount of recombinant Klf4 and increasing amounts of Klf5. (D) EMSAs were performed with a constant amount of recombinant Klf5 and increasing amounts of Klf4.
###end p 38
###begin title 39
ACKNOWLEDGEMENTS
###end title 39
###begin p 40
We thank Dr Jerry Lingrel for providing reagents. This work was supported in part by grants from the National Institutes of Health (DK52230 and CA84197 to V.W.Y. and DK59970 to D.T.D.). D.T.D. is a recipient of an American Digestive Health Foundation/American Gastroenterological Association Research Scholar Award and a Glaxo Institute for Digestive Health Basic Research Award.
###end p 40
###begin title 41
REFERENCES
###end title 41

